Ocugen_May_2021_695_69695
Loading viewer...
investor_presentation
Format: PDF investor_presentation
Ocugen's May 2021 corporate deck outlines its mission to develop gene therapies for blindness and a COVID-19 vaccine, highlighting future strategies and market potential.
